J R Martinez-Parachini1, A Karatasakis1, D Karmpaliotis2, K Alaswad3, F A Jaffer4, R W Yeh5, M Patel6, J Bahadorani6, A Doing7, P-K Nguyen-Trong1, B A Danek1, J Karacsonyi1, A Alame1, B V Rangan1, C A Thompson8, S Banerjee1, E S Brilakis1,9. 1. VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX, USA. 2. Columbia University, New York, NY, USA. 3. Henry Ford Hospital, Detroit, MI, USA. 4. Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 5. Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. 6. VA San Diego Healthcare System and University of California San Diego, San Diego, CA, USA. 7. Medical Center of the Rockies, Loveland, CO, USA. 8. Boston Scientific, Natick, MA, USA. 9. Minneapolis Heart Institute, Minneapolis, MN, USA.
Abstract
AIM: To examine the impact of diabetes mellitus on procedural outcomes of patients who underwent percutaneous coronary intervention for chronic total occlusion. METHODS: We assessed the impact of diabetes mellitus on the outcomes of percutaneous coronary intervention for chronic total occlusion among 1308 people who underwent such procedures at 11 US centres between 2012 and 2015. RESULTS: The participants' mean ± sd age was 66 ± 10 years, 84% of the participants were men and 44.6% had diabetes. As compared with participants without diabetes, participants with diabetes were more likely to have undergone coronary artery bypass graft surgery (38 vs 31%; P = 0.006), and to have had previous heart failure (35 vs 22%; P = 0.0001) and peripheral arterial disease (19 vs 13%; P = 0.002). They also had a higher BMI (31 ± 6 kg/m2 vs 29 ± 6 kg/m2 ; P = 0.001), similar Japanese chronic total occlusion scores (2.6 ± 1.2 vs 2.5 ± 1.2; P = 0.82) and similar final successful crossing technique: antegrade wire escalation (46 vs 47%; P = 0.66), retrograde (30 vs 28%; P = 0.66) and antegrade dissection re-entry (24 vs 25%; P = 0.66). Technical (91 vs 90%; P = 0.80) and procedural (89 vs 89%; P = 0.93) success was similar in the two groups, as was the incidence of major adverse cardiac events (2.2 vs 2.5%; P = 0.61). CONCLUSIONS: In a contemporary cohort of people undergoing percutaneous coronary intervention for chronic total occlusion, nearly one in two (45%) had diabetes mellitus. Procedural success and complication rates were similar in people with and without diabetes.
AIM: To examine the impact of diabetes mellitus on procedural outcomes of patients who underwent percutaneous coronary intervention for chronic total occlusion. METHODS: We assessed the impact of diabetes mellitus on the outcomes of percutaneous coronary intervention for chronic total occlusion among 1308 people who underwent such procedures at 11 US centres between 2012 and 2015. RESULTS: The participants' mean ± sd age was 66 ± 10 years, 84% of the participants were men and 44.6% had diabetes. As compared with participants without diabetes, participants with diabetes were more likely to have undergone coronary artery bypass graft surgery (38 vs 31%; P = 0.006), and to have had previous heart failure (35 vs 22%; P = 0.0001) and peripheral arterial disease (19 vs 13%; P = 0.002). They also had a higher BMI (31 ± 6 kg/m2 vs 29 ± 6 kg/m2 ; P = 0.001), similar Japanese chronic total occlusion scores (2.6 ± 1.2 vs 2.5 ± 1.2; P = 0.82) and similar final successful crossing technique: antegrade wire escalation (46 vs 47%; P = 0.66), retrograde (30 vs 28%; P = 0.66) and antegrade dissection re-entry (24 vs 25%; P = 0.66). Technical (91 vs 90%; P = 0.80) and procedural (89 vs 89%; P = 0.93) success was similar in the two groups, as was the incidence of major adverse cardiac events (2.2 vs 2.5%; P = 0.61). CONCLUSIONS: In a contemporary cohort of people undergoing percutaneous coronary intervention for chronic total occlusion, nearly one in two (45%) had diabetes mellitus. Procedural success and complication rates were similar in people with and without diabetes.
Authors: Emmanouil S Brilakis; J Aaron Grantham; Stéphane Rinfret; R Michael Wyman; M Nicholas Burke; Dimitri Karmpaliotis; Nicholas Lembo; Ashish Pershad; David E Kandzari; Christopher E Buller; Tony DeMartini; William L Lombardi; Craig A Thompson Journal: JACC Cardiovasc Interv Date: 2012-04 Impact factor: 11.195
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Khaldoon Alaswad; Rohan V Menon; Georgios Christopoulos; William L Lombardi; Dimitri Karmpaliotis; J Aaron Grantham; Steven P Marso; Michael R Wyman; Nagendra R Pokala; Siddharth M Patel; Anna P Kotsia; Bavana V Rangan; Nicholas Lembo; David Kandzari; James Lee; Anna Kalynych; Harold Carlson; Santiago A Garcia; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis Journal: Catheter Cardiovasc Interv Date: 2015-02-03 Impact factor: 2.692
Authors: Georgios Christopoulos; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; R Michael Wyman; William L Lombardi; Rohan V Menon; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Muhammad Nauman J Tarar; Georgios E Christakopoulos; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis Journal: Int J Cardiol Date: 2015-06-27 Impact factor: 4.164
Authors: Alfredo R Galassi; Salvatore D Tomasello; Nicolaus Reifart; Gerald S Werner; George Sianos; Hans Bonnier; Horst Sievert; Stephan Ehladad; Alexander Bufe; Joachim Shofer; Anthony Gershlick; David Hildick-Smith; Javier Escaned; Andrejs Erglis; Imad Sheiban; Leif Thuesen; Anthony Serra; Evald Christiansen; Achim Buettner; Luca Costanzo; Giombattista Barrano; Carlo Di Mario Journal: EuroIntervention Date: 2011-08 Impact factor: 6.534
Authors: James Sapontis; Georgios Christopoulos; J Aaron Grantham; R Michael Wyman; Khaldoon Alaswad; Dimitri Karmpaliotis; William L Lombardi; James M McCabe; Steven P Marso; Anna P Kotsia; Bavana V Rangan; Georgios E Christakopoulos; Santiago Garcia; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis Journal: Catheter Cardiovasc Interv Date: 2015-02-03 Impact factor: 2.692
Authors: Georgios Christopoulos; David E Kandzari; Robert W Yeh; Farouc A Jaffer; Dimitri Karmpaliotis; Michael R Wyman; Khaldoon Alaswad; William Lombardi; J Aaron Grantham; Jeffrey Moses; Georgios Christakopoulos; Muhammad Nauman J Tarar; Bavana V Rangan; Nicholas Lembo; Santiago Garcia; Daisha Cipher; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis Journal: JACC Cardiovasc Interv Date: 2016-01-11 Impact factor: 11.195